BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28874699)

  • 21. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats.
    Tarohda T; Ishida Y; Kawai K; Yamamoto M; Amano R
    Anal Bioanal Chem; 2005 Sep; 383(2):224-34. PubMed ID: 16132122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anterior olfactory nucleus in Parkinson's disease.
    Pearce RK; Hawkes CH; Daniel SE
    Mov Disord; 1995 May; 10(3):283-7. PubMed ID: 7651444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Mohedano-Moriano A; Fradejas N; Calvo S; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Mov Disord; 2010 Aug; 25(11):1701-7. PubMed ID: 20574962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficits in olfactory sensitivity in a mouse model of Parkinson's disease revealed by plethysmography of odor-evoked sniffing.
    Johnson ME; Bergkvist L; Mercado G; Stetzik L; Meyerdirk L; Wolfrum E; Madaj Z; Brundin P; Wesson DW
    Sci Rep; 2020 Jun; 10(1):9242. PubMed ID: 32514004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.
    Beauchamp LC; Chan J; Hung LW; Padman BS; Vella LJ; Liu XM; Coleman B; Bush AI; Lazarou M; Hill AF; Jacobson L; Barnham KJ
    Acta Neuropathol Commun; 2018 Jul; 6(1):57. PubMed ID: 29976255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Tremblay C; Aslam S; Walker JE; Lorenzini I; Intorcia AJ; Arce RA; Choudhury P; Adler CH; Shill HA; Driver-Dunckley E; Mehta S; Piras IS; Belden CM; Atri A; Beach TG; Serrano GE
    Neurobiol Dis; 2024 Jun; 196():106514. PubMed ID: 38663633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
    Lachén-Montes M; González-Morales A; Iloro I; Elortza F; Ferrer I; Gveric D; Fernández-Irigoyen J; Santamaría E
    Neurobiol Aging; 2019 Jan; 73():123-134. PubMed ID: 30342273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms].
    Takeda A; Baba T; Kikuchi A; Sugeno N; Hasegawa T; Itoyama Y; Ishioka T; Hirayama K; Mori E
    Rinsho Shinkeigaku; 2009 Nov; 49(11):888-9. PubMed ID: 20030239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
    Pal GD; Ouyang B; Serrano G; Shill HA; Goetz C; Stebbins G; Metman LV; Driver-Dunckley E; Mehta SH; Caviness JN; Sabbagh MN; Adler CH; Beach TG;
    Mov Disord; 2017 Feb; 32(2):274-277. PubMed ID: 27911008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
    Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
    Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures.
    Bagnoli E; Trotier A; McMahon J; Quinlan LR; Biggs M; Pandit A; FitzGerald U
    FASEB J; 2023 Dec; 37(12):e23272. PubMed ID: 37997495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
    Riederer P; Sofic E; Rausch WD; Schmidt B; Reynolds GP; Jellinger K; Youdim MB
    J Neurochem; 1989 Feb; 52(2):515-20. PubMed ID: 2911028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.
    Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL
    Metallomics; 2017 Oct; 9(10):1447-1455. PubMed ID: 28944802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease.
    Yeager MP; Coleman RA
    J Neurosci Methods; 2010 Apr; 188(1):151-64. PubMed ID: 20144654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders.
    Saito Y; Shioya A; Sano T; Sumikura H; Murata M; Murayama S
    Mov Disord; 2016 Jan; 31(1):135-8. PubMed ID: 26748832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
    Dexter DT; Jenner P; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.